FHLTU
Income statement / Annual
Last year (2023), Future Health ESG Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Future Health ESG Corp.'s net income was -$48,425.00.
See Future Health ESG Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$627,731.00
|
$2.21 M
|
$150,005.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$124,853.00
|
| Selling, General &
Administrative Expenses |
$627,731.00
|
$2.21 M
|
$125,004.00
|
| Other Expenses |
$0.00 |
$200,531.00 |
-$62,300.00 |
| Operating Expenses |
$678,591.00 |
$2.41 M |
$187,304.00 |
| Cost And Expenses |
$678,591.00 |
$2.41 M |
$187,303.00 |
| Interest Income |
$784,158.00 |
$10,332.00 |
$6,392.00 |
| Interest Expense |
$0.00 |
$10,332.00 |
-$6,392.00 |
| Depreciation &
Amortization |
$1.00
|
-$2.60 M
|
$6,392.00
|
| EBITDA |
-$678,590.00
|
-$5.01 M
|
-$187,300.00
|
| EBITDA Ratio |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$784,158.00
|
$2.61 M
|
$6,389.00
|
| Income Before Tax |
$105,567.00 |
$204,617.00 |
-$180,911.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
| Income Tax Expense |
$153,992.00 |
$144,810.00 |
-$6,392.00 |
| Net Income |
-$48,425.00 |
$59,807.00 |
-$180,911.00 |
| Net Income Ratio |
0 |
0 |
0 |
| EPS |
-0.0074 |
0.0025 |
-0.0072 |
| EPS Diluted |
-0.0074 |
0.0025 |
-0.0072 |
| Weighted Average Shares
Out |
$6.59 M
|
$24.19 M
|
$25.00 M
|
| Weighted Average Shares
Out Diluted |
$6.59 M
|
$24.19 M
|
$25.00 M
|
| Link |
|
|
|
